The Surgical Instrument Tracking System Market is expected to grow with a wholesome growth rate of more than 15% over the forecast period 2022-2032, finds Future Market Insights (FMI) in a recent market analysis. With the need to reduce costs and increase productivity, tracking systems are becoming more popular among healthcare providers. The US FDA’s (Food …
Category Archives: Healthcare Trends
Self Testing Market is projected to record a CAGR of 5.6% amid the forecast period by 2030
As per the latest market study by Future Market Insights (FMI), the global self-testing market is projected to record a CAGR of 5.6% amid the forecast period, 2022-2030. Consumers are swiftly adapting to buy self-testing kits due to early detection of severe allergies or diseases with the assistance of STI/STD self-tests, cancer-tests, and intolerance self-tests. Pharmacies …
Over-The-Counter Pain Medication Market Is Set to Expand at A CAGR Of 4.1% To Reach US$ 27.7 Billion During the Forecast Period 2022-2028
The OTC (over-the-counter) pain medication market surpassed US$ 18 billion in 2018, with growth influenced by changing perceptions on generic pharmaceutical drugs, according to a recent study published by Future Market Insights (FMI). The study opines that market revenue will rev up at an improved rate of 3.7% to exceed US$ 19.3 billion in 2019. …
Orthopaedic Prosthetics Market will witness a CAGR of over 4.5% through 2030
As per Future Market Insights (FMI) – an ESOMAR-certified market research firm, global orthopaedic prosthetics market will be worth US$ 3.22 Bn by 2030. Orthopaedic prosthetics have been witnessing personalized breakthrough innovations since the last few years. The market is witnessing customized prosthetics that enable modifications on the basis of functionality and anatomy of the respective patient. According to FMI, …
Continue reading “Orthopaedic Prosthetics Market will witness a CAGR of over 4.5% through 2030”
Oral Antiseptics Market Is Set to Expand at A CAGR Of 4.7% To Reach US$ 3.24 Billion During the Forecast Period 2022-2028
The global Oral Antiseptics Market is slated to be valued at US$ 2.47 Bn in 2022. Sales of oral antiseptics are predicted to increase at a CAGR of 4.7% from 2022 to 2028 and reach a valuation of US$ 3.24 Bn by 2028. Oral antiseptics worth US$ 2 billion were sold by the end of 2018, according to a new research intelligence by …
Over-the-Counter Pain Medication Market is estimated to attain a valuation of US$ 27.7 Billion by the end of 2028
Top Companies Covered in Over-the-Counter Pain Medication Market Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A.,GlaxoSmithKline plc., Bristo-Meyers Squibb and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Merck & o., Cardinal Health Inc. DUBAI, United Arab Emirates, April 11, 2022 (GLOBE NEWSWIRE) — The OTC (over-the-counter) pain medication market surpassed US$ 21.8 billion in …
Dental Lasers Market Is Anticipated to Grow Significantly to Reach US$ 560.4 Million By the Year 2026
The global demand for dental lasers has been envisaged to grow steadily in 2022, representing a growth rate of nearly 4.5%. According to a business intelligence report on the global dental lasers adoption, the Dental Lasers Market is likely to surpass a value of US$ 560.4 million in terms of revenue, indicating an increase of 1.4x in …
Oxytocic Pharmaceuticals Market Is Set to Expand at A CAGR Of 7.74% To Reach US$ 207.80 Million During the Forecast Period 2021-2031
Increasing childbirth using labor induction is expected to be the key factor driving the growth of oxytocic pharmaceuticals market. As per FMI, growing awareness regarding C-section and its related benefits across the globe has spurred the demand for synthetic oxytocin. The market will exhibit stellar growth as the prevalence of post-partum hemorrhage continues to increase …
Seasonal Affective Disorder Therapeutics Market Is Set to Expand at A CAGR Of 4.3% To Reach US$ 1.1 Billion During the Forecast Period 2022-2028
The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder …
Implantable Drug Eluting Devices Market Is Set to Expand at A CAGR Of 6.0% To Reach US$ 19.3 Billion During the Forecast Period 2022-2029
Analysts at Future Market Insights find that the global Implantable Drug Eluting Devices Market during the historic period 2014-2018. The market study suggests that the global market size of Implantable Drug-Eluting Devices is projected to reach ~US$ 10.7 Bn by the end of 2022 with a CAGR of 6% over the stipulated timeframe 2022-2029. The COVID-19 pandemic has been …